Moscow-Sana
The Russian Federal Authority for Consumer Rights Protection announced that the efficacy of the (ABVAC Corona) vaccine against Corona reaches 100 percent, according to the results of the first and second stages of clinical tests.
The media office of RIA Novosti indicated today that the presence of antibodies to the Corona virus in a person is not a factor that prevents him from receiving this vaccine, explaining that “my father fak Corona” enhances his body’s immunity.
The office explained that the vaccination with the aforementioned vaccine, which was developed at the Victor Scientific Center in Novosibirsk and was officially registered last October, requires an injection of a dose of it twice with an interval of two to three weeks.
At the present time, (Abi Fak Corona) is still in the third phase of clinical tests, in which 40,000 volunteers are participating, including those over 60 years old and those with chronic diseases.